Market Overview:

The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Intravenous (IV) solutions are supplemental fluids comprising water, electrolytes, sugar, and medications. They are given to patients according to their requirements, medical condition, age, and body size to restore fluid volume and treat electrolyte balance. At present, they are widely used in IV therapy to replace electrolyte losses, administer drugs and blood products, and supply essential nutrients to the intravascular fluid compartment.

Intravenous Solutions Market Trends:

Due to the sudden outbreak of coronavirus disease (COVID-19), there is a rise in the demand for IV solutions worldwide to provide essential nutrients to patients in the intensive care unit (ICU). Apart from this, the increasing number of people who have diabetes, cancer, gastrointestinal disorder, and neurological diseases represents another major growth-inducing factor. Moreover, the faster response time and higher efficacy associated with IV solution therapy is contributing to market growth. It is used to overcome chronic dehydration that can cause fatigue, memory problems, irritability, and other medical conditions. This, along with the increasing participation of individuals in physical activities, is influencing the adoption of IV solutions for a fast recovery. IV solutions are also utilized to improve skin conditions and treat migraines and hangovers. Besides this, leading manufacturers are introducing easy-to-use, portable product variants that can be used as drips at home. Additionally, due to rising environmental concerns, they are developing premixed solutions that reduce the amount of packaging waste. Furthermore, rising investments by health agencies of numerous countries in the healthcare sector are anticipated to create a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous solutions market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on type and nutrients.

Breakup by Type:

• Partial Parenteral Nutrition 
• Total Parenteral Nutrition
   

Total parenteral nutrition is currently the most preferred type of IV solution as it helps prevent malnutrition and maintain energy.

Breakup by Nutrients:

• Carbohydrates
• Salts and Electrolytes
• Minerals
• Vitamins
• Amino Acids 
   

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
   

Presently, North America enjoys the leading position in the market due to the increasing prevalence of chronic diseases in the region.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical.

Report Coverage: